Department of Genetics and Metabolism, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Key Laboratory of Diagnosis and Treatment of Neonatal Diseases of Zhejiang Province, Hangzhou, China.
Brain Behav. 2020 Sep;10(9):e01724. doi: 10.1002/brb3.1724. Epub 2020 Jul 14.
Mutations within TFG gene were recently reported to cause Charcot-Marie-Tooth disease 2 (CMT2). However, only few pedigrees were documented so far. Here, we reported a Chinese CMT2 pedigree with 8 affected cases and a novel TFG mutation.
Clinical evaluation and electrophysiological study were performed in all the affected individuals. Whole-exome sequencing was conducted, followed by the Sanger sequencing and co-segregation analysis to verify the variants.
All cases presented with a phenotype of CMT2, including slowly progressive symmetrical muscle atrophy and weakness predominantly in the distal limbs. Sensory loss in the distal limbs was present in the proband and his father. Age at onset ranged from 37 to 44 years, and was younger in male cases, compared with female cases. Nerve conduction study revealed normal motor nerve conduction velocity but decreased compound muscle action potential. Electromyography test revealed fibrillation potential and positive sharp waves. The creatine kinase activity was increased in all cases. After genetic investigations, we identified a novel TFG c.793C>G (p.Pro265Ala) mutation in the family. This mutation alters the conserved amino acid residue and is absent in 1000G, ExAC, dbSNP, EP6500, and 200 in-house controls. It co-segregated with the disease in the family.
Our report provided additional evidence that the heterozygous TFG mutations were associated with CMT2.
TFG 基因内的突变最近被报道可导致 2 型腓骨肌萎缩症(CMT2)。然而,迄今为止仅记录了少数家系。在此,我们报道了一个中国 CMT2 家系,共 8 名受影响个体,存在一个新的 TFG 突变。
对所有受影响个体进行临床评估和电生理学研究。进行全外显子组测序,然后进行 Sanger 测序和共分离分析以验证变异。
所有病例均表现为 CMT2 表型,包括缓慢进行性对称性肌肉萎缩和四肢远端无力。症状在受累者及其父亲中表现为四肢远端感觉丧失。发病年龄从 37 岁到 44 岁不等,男性病例较女性病例更年轻。神经传导研究显示运动神经传导速度正常,但复合肌肉动作电位降低。肌电图检查显示纤颤电位和正锐波。所有病例的肌酸激酶活性均升高。经过基因调查,我们在该家系中发现了 TFG 基因的一个新突变 c.793C>G(p.Pro265Ala)。该突变改变了保守的氨基酸残基,并且在 1000G、ExAC、dbSNP、EP6500 和 200 个内部对照中不存在。该突变在家系中与疾病共分离。
我们的报告提供了额外的证据,表明杂合 TFG 突变与 CMT2 相关。